TITLE

Diabetes, protease-inhibitor link unproved: directorate

PUB. DATE
September 1997
SOURCE
CMAJ: Canadian Medical Association Journal;09/01/97, Vol. 157 Issue 5, p502
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
States that the Therapeutic Drugs Directorate at Health Canada find no conclusive evidence to support a causal relationship between protease inhibitors and diabetes or hyperglycemia in HIV-infected patients.
ACCESSION #
9709112528

 

Related Articles

  • Canadian drug surveillance: A sick system? Peskett, Trudy // Alive: Canada's Natural Health & Wellness Magazine;Sep2003, Issue 251, p172 

    Discusses the role of Health Canada's Therapeutic Products Directorate in approving and monitoring drugs. Examples of drugs that has an adverse reaction; Number of adverse drug reaction reports received by Health Canada.

  • Regulatory Regime.  // Canada Pharma & Healthcare Report;Q2 2012, Issue 2, p14 

    The article discusses the regulation of the pharmaceutical industry in Canada in 2012. It indicates the authority of the Therapeutic Products Directorate of the Ministry of Health to regulate the industry. It states the requirement that a drug company must provide scientific evidence confirming...

  • Regulatory Regime.  // Canada Pharma & Healthcare Report;Q3 2011, Issue 3, p14 

    The article focuses on regulatory developments in the Canadian pharmaceutical industry. The Canadian health ministry (Health Canada) Therapeutic Products Directorate obliges companies to give scientific proofs on the effectiveness, quality, and safety of their medical products in compliance to...

  • CEL-SCI Corp Receives Final Canadian Government Approval to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer.  // Biomedical Market Newsletter;5/5/2011, p656 

    The article reports on the approval of the government on CEL-SCI Corp.'s Phase III clinical trial of multikine in head and neck cancer in Canada. It states that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued the final approval for the trial, which is expected to...

  • Health Canada approves rapid HIV test for sale in Canada. Garmaise, David // HIV/AIDS Policy & Law Review;Dec2004, Vol. 9 Issue 3, p30 

    The article reports that on 12 October 2004 the Medical Devices Bureau of the Therapeutic Products Directorate, Health Canada has approved for sale in Canada a rapid test for HIV antibodies. The test detects HIV antibodies in blood plasma or serum in under three minutes, and is intended for use...

  • FDA's approval of anesthetic challenged following deaths. Sibbald, Barbara // CMAJ: Canadian Medical Association Journal;6/24/2003, Vol. 168 Issue 13, p1698 

    Reports on a letter sent by Canadian researcher Robyn Lim to the journal 'Anesthesia & Analgesia' that questions the decision of the United States Food and Drug Administration (FDA) to approve the use of the injectable anesthetic rapacuronium. Response of the FDA to the incidence of...

  • Speed up drug-approval process, feds told. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;3/5/2002, Vol. 166 Issue 5, p644 

    Comments on the drug-review system and approval process in Canada, which was the focus of the Canadians for Best Medicines Second National Summit on Reform of the Drug Review System held in Aylmer, Quebec in January 2002. Examples of the number of days that Health Canada takes to approve drugs;...

  • MARKETPLACE.  // Oncology Exchange;Nov2012, Vol. 11 Issue 4, p54 

    The article highlights decisions based on evidence of safety and efficacy pertaining to marketing of new oncology products or indications, by the Therapeutics Products Directorate (TPD) division of Health Canada and the U.S. Food and Drug Administration (FDA). These oncology products include...

  • Drug Approval.  // Psychostimulants as Antidepressants: Worth the Risk?;2007, p46 

    The article discusses on the agency that process the approval of drugs in the Canada and the U.S. The Food and Drug Administration is the consumer protection in the U.S., it operates given by the government guided by law to verify safety, effectiveness and accuracy of labeling for any drug...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics